Our phenotypical, transcriptional, and functional analysis identified CD64 and CCR2 as markers of activated migratory CD1c+ cDC enriched in the inflamed joint from patients with RA, which are selectively restored in the PB after treatment initiation and reduction of clinical severity. The gene discussed is CCR2; the disease is rheumatoid arthritis.